The Forensic Science Commission held its quarterly meeting on April 11, 2025, focusing on critical issues surrounding THC analysis in forensic labs. The meeting addressed the complexities of distinguishing between tetrahydrocannabinolic acid (THCA) and tetrahydrocannabinol (THC), particularly in non-plant matrices such as vape liquids and oils.

The discussion began with an overview of a complaint from Mr. Shubman, who argued that a lack of clarity in lab testing methods contributed to his eviction. The commission noted that while the complaint fell outside its jurisdiction, it highlighted significant issues in how labs report THC levels. The distinction between THCA, which is non-psychoactive, and THC, which is psychoactive, is crucial, especially as legislative measures are being considered to regulate THC products more strictly.

Commission members reviewed various testing methods employed by different labs, noting that some labs can differentiate between THCA and THC, while others cannot. The Department of Public Safety (DPS) was mentioned as one of the labs that currently lacks the capability to make this distinction, which has led to a backlog in testing and case processing.

To address these issues, the commission proposed changes to reporting language for labs that cannot differentiate between THCA and THC. The recommendation emphasizes that reports should clearly indicate whether the results pertain to THC, THCA, or a combination of both. This clarity is essential for compliance with accreditation requirements and to ensure that end users understand the limitations of the testing methods used.

The urgency of these recommendations was underscored by the current legislative climate, where bills are being introduced that could make all THC products illegal, including THCA. The commission aims to provide labs with clear guidance to navigate these changes and improve the accuracy of their reporting.

In conclusion, the meeting highlighted the need for improved clarity in THC reporting methods and the importance of addressing legislative developments that could impact the forensic analysis of cannabis products. The commission plans to follow up with the DPS and other stakeholders to implement these recommendations effectively.